HLS Therapeutics Revenue

HLS Therapeutics had revenue of $12.62M in the quarter ending March 31, 2025, with 1.20% growth. This brings the company's revenue in the last twelve months to $56.77M, down -6.61% year-over-year. In the year 2024, HLS Therapeutics had annual revenue of $56.62M, down -10.23%.

Revenue (ttm)

56.77M

Revenue Growth

-6.61%

P/S Ratio

2.00

Revenue / Employee

617.05K

Employees

Market Cap

113.71M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	56.62M	-6.46M	-10.23%
Dec 31, 2023	63.07M	1.61M	2.61%
Dec 31, 2022	61.47M	1.46M	2.43%
Dec 31, 2021	60.01M	3.90M	6.95%
Dec 31, 2020	56.11M	1.95M	3.60%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.73B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Elite Pharmaceuticals	70.00M
Glass House Brands	215.62M
Northwest Biotherapeutics	1.47M
American Oncology Network	1.76B
Silence Therapeutics	27.70M

Revenue Rankings

HLS Therapeutics News

4 weeks ago - HLS Therapeutics reports Q1 results - Seeking Alpha
4 weeks ago - HLS Therapeutics Announces Q1 2025 Financial Results - Benzinga
3 months ago - HLS Therapeutics GAAP EPS of -$0.10, revenue of $15.5M misses by $0.2M - Seeking Alpha
3 months ago - HLS Therapeutics Announces Fiscal 2024 Financial Results and Normal Course Issuer Bid - Benzinga
7 months ago - HLS Therapeutics GAAP EPS of -$0.15 beats by $0.04, revenue of $14.08M misses by $6.42M - Seeking Alpha

More News